# FeNO as a Marker of Allergic Reactions to OFC and Response of OMA Treatment in Multiple FA

> **NCT06437171** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **AAADRS Clinical Research Center** · enrollment: 20 (estimated)

## Conditions studied

- Food Allergy

## Interventions

- **BIOLOGICAL:** Omalizumab

## Key facts

- **NCT ID:** NCT06437171
- **Lead sponsor:** AAADRS Clinical Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-03
- **Primary completion:** 2026-07
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06437171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06437171, "FeNO as a Marker of Allergic Reactions to OFC and Response of OMA Treatment in Multiple FA". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06437171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*